Brilinta
Payments companies reported to CMS as associated with Brilinta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Brilinta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Brilinta
These are the largest totals companies reported as associated with Brilinta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ziad Ali | New York, NY | Internal Medicine | $25,119.14 |
| Amir Piracha | Louisville, KY | Cardiovascular Disease | $24,226.05 |
| John Isaac | Houston, TX | Interventional Cardiology | $16,871.84 |
| Raghava Gollapudi | San Diego, CA | Interventional Cardiology | $12,742.47 |
| Sorin Brener | Brooklyn, NY | Interventional Cardiology | $10,417.17 |
| James Bennett | Jackson, MS | Interventional Cardiology | $7,816.16 |
| Joshua Stolker | Washington, MO | Interventional Cardiology | $6,817.01 |
| Warren Wexelman | Brooklyn, NY | Cardiovascular Disease | $5,934.93 |
| Daniel Stewart | Louisville, KY | Interventional Cardiology | $5,717.05 |
| Miguel Diaz | Hialeah, FL | Interventional Cardiology | $5,420.92 |
Prescribed Brilinta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.